(19)
(11) EP 0 783 516 A1

(12)

(43) Date of publication:
16.07.1997 Bulletin 1997/29

(21) Application number: 95932443.0

(22) Date of filing: 18.09.1995
(51) International Patent Classification (IPC): 
C12N 15/ 09( . )
A61K 51/ 00( . )
C07K 7/ 06( . )
C07K 14/ 54( . )
C07K 19/ 00( . )
C12R 1/ 19( . )
A61K 38/ 00( . )
C07K 1/ 13( . )
C07K 7/ 08( . )
C07K 16/ 30( . )
C12P 21/ 02( . )
(86) International application number:
PCT/US1995/011405
(87) International publication number:
WO 1996/008506 (21.03.1996 Gazette 1996/13)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
LT LV SI

(30) Priority: 16.09.1994 US 19940308103

(71) Applicant: Immunomedics, Inc.
Morris Plains, New Jersey 07950 (US)

(72) Inventors:
  • LEUNG, Shui-on
    Madison, NJ 07940 (US)
  • HANSEN, Hans J.
    Mystic Island, NJ 08087 (US)
  • GRIFFITHS, Gary L.
    Morristown, NJ 07960 (US)

(74) Representative: Mercer, Christopher Paul 
Carpmaels & Ransford 43, Bloomsbury Square
London WC1A 2RA
London WC1A 2RA (GB)

   


(54) PHOSPHORUS-32 LABELING OF ANTIBODIES FOR CANCER THERAPY